2. Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. 2009; The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 68:777–83. Erratum. DOI:
10.1136/ard.2009.108233corr1. PMID:
31088800.
Article
4. Pathan EMI, Inman RD. 2021; Pain in axial spondyloarthritis: insights from immunology and brain imaging. Rheum Dis Clin North Am. 47:197–213. DOI:
10.1016/j.rdc.2020.12.007. PMID:
33781490.
8. Adami G, Gerratana E, Atzeni F, Benini C, Vantaggiato E, Rotta D, et al. 2021; Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? Ther Adv Musculoskelet Dis. 13:1759720X21993252. DOI:
10.1177/1759720X21993252. PMID:
33643445. PMCID:
PMC7890747.
Article
9. Dumolard A, Lefaucheur JP, Hodaj E, Liateni Z, Payen JF, Hodaj H. 2023; Central sensitization and small-fiber neuropathy are associated in patients with fibromyalgia. Clin J Pain. 39:8–14. DOI:
10.1097/AJP.0000000000001085. PMID:
36524768.
Article
10. Kieskamp SC, Paap D, Carbo MJG, Wink F, Bos R, Bootsma H, et al. 2022; Central sensitization has major impact on quality of life in patients with axial spondyloarthritis. Semin Arthritis Rheum. 52:151933. DOI:
10.1016/j.semarthrit.2021.11.006. PMID:
35033996.
Article
11. Kieskamp SC, Paap D, Carbo MJG, Wink F, Bos R, Bootsma H, et al. 2021; Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis. Rheumatology (Oxford). 60:4476–85. DOI:
10.1093/rheumatology/keab019. PMID:
33492397. PMCID:
PMC8487271.
Article
12. Aykurt Karlıbel I, Kasapoğlu Aksoy M. 2023; The relationship between central sensitization and disease activity, quality of life, and sleep quality among patients with axial spondyloarthritis. Ir J Med Sci. 192:481–9. DOI:
10.1007/s11845-022-02957-4. PMID:
35226249.
Article
13. Mogard E, Lindqvist E, Bremander A, Bergman S. 2019; Risk factors for development and persistence of chronic widespread pain in spondyloarthritis: a population-based two-year follow-up study. Scand J Rheumatol. 48:460–8. DOI:
10.1080/03009742.2019.1602163. PMID:
31244357.
Article
14. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, Landewé R, van ver Tempel H, Mielants H, et al. 2003; Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis. 62:127–32. DOI:
10.1136/ard.62.2.127. PMID:
12525381. PMCID:
PMC1754445.
Article
15. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. 1994; A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 21:2281–5.
16. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. 1994; A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 21:2286–91.
17. Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A. 1994; Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol. 21:1694–8.
18. van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, et al. 2009; ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis. 68:1811–8. DOI:
10.1136/ard.2008.100826. PMID:
19060001.
Article
19. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. 2010; The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 62:600–10. DOI:
10.1002/acr.20140. PMID:
20461783.
Article
20. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. 2005; Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 114:29–36. DOI:
10.1016/j.pain.2004.12.010. PMID:
15733628.
Article
21. Coronado RA, George SZ. 2018; The Central Sensitization Inventory and Pain Sensitivity Questionnaire: an exploration of construct validity and associations with widespread pain sensitivity among individuals with shoulder pain. Musculoskelet Sci Pract. 36:61–7. DOI:
10.1016/j.msksp.2018.04.009. PMID:
29751194. PMCID:
PMC6671673.
Article
22. Guler MA, Celik OF, Ayhan FF. 2020; The important role of central sensitization in chronic musculoskeletal pain seen in different rheumatic diseases. Clin Rheumatol. 39:269–74. DOI:
10.1007/s10067-019-04749-1. PMID:
31446538.
Article
24. Serrano-Ibáñez ER, Esteve R, Ramírez-Maestre C, Ruiz-Párraga GT, López-Martínez AE. 2021; Chronic pain in the time of COVID-19: stress aftermath and central sensitization. Br J Health Psychol. 26:544–52. DOI:
10.1111/bjhp.12483. PMID:
33099793.
Article
25. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, et al. 2016; 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 46:319–29. DOI:
10.1016/j.semarthrit.2016.08.012. PMID:
27916278.
Article
26. Koca TT, Göğebakan H, Çetin G. 2019; Should central sensitization and neuropathic pain be considered in disease activity and treatment decision in axial ankylosing spondilitis? Cukurova Med J. 44(Suppl 1):1–10. DOI:
10.17826/cumj.503652.
Article
27. Baraliakos X, Regel A, Kiltz U, Menne HJ, Dybowski F, Igelmann M, et al. 2018; Patients with fibromyalgia rarely fulfil classification criteria for axial spondyloarthritis. Rheumatology (Oxford). 57:1541–7. DOI:
10.1093/rheumatology/kex318. PMID:
28968885.
Article
28. Bello N, Etcheto A, Béal C, Dougados M, Moltó A. 2016; Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis. Arthritis Res Ther. 18:42. DOI:
10.1186/s13075-016-0943-z. PMID:
26860612. PMCID:
PMC4748456.
Article
29. Ablin JN, Eshed I, Berman M, Aloush V, Wigler I, Caspi D, et al. 2017; Prevalence of axial spondyloarthritis among patients with fibromyalgia: a magnetic resonance imaging study with application of the Assessment of SpondyloArthritis International Society classification criteria. Arthritis Care Res (Hoboken). 69:724–9. DOI:
10.1002/acr.22967. PMID:
27390225.
Article
30. Bouhassira D, Lantéri-Minet M, Attal N, Laurent B, Touboul C. 2008; Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 136:380–7. DOI:
10.1016/j.pain.2007.08.013. PMID:
17888574.
Article